Free Trial
→ SpaceX eyes a 1.75 trillion valuation - here's what to know (From Brownstone Research) (Ad)tc pixel
NASDAQ:OSRH

OSR 5/20/2025 Earnings Report

OSR logo
$0.60 -0.02 (-2.69%)
Closing price 05/14/2026 04:00 PM Eastern
Extended Trading
$0.59 -0.01 (-1.50%)
As of 06:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

OSR EPS Results

Actual EPS
-$1.04
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

OSR Revenue Results

Actual Revenue
$0.76 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

OSR Announcement Details

Quarter
Date
5/20/2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

OSR Earnings Headlines

OSR Holdings, Inc. (NASDAQ:OSRH) Short Interest Update
May 13 at 1:06 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30774579
OSR Holdings, Inc. Common Stock (OSRH) SEC Filings
May 2, 2026  |  nasdaq.comhttps://www.nasdaq.com/market-activity/stocks/osrh/sec-filings
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a $1.75 trillion IPO - larger than Saudi Aramco and any tech offering in history. CNBC calls it 'the big market event of 2026.' According to former tech executive and angel investor Jeff Brown, there's a way to claim a stake before the public filing drops, starting with as little as $500.tc pixel
May 15 at 1:00 AM  |  Brownstone Research (Ad)
OSRH stock rockets 60% on $815M immunotherapy deal — retail bulls eye $1 mark for the stock
April 30, 2026  |  msn.comhttps://www.msn.com/en-us/health/other/osrh-stock-rockets-60-on-815m-immunotherapy-deal-retail-bulls-eye-1-mark-for-the-stock/ar-AA2272q4
OSR Holdings Appoints New COO to Bolster Healthcare Focus
April 22, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/osr-holdings-appoints-new-coo-to-bolster-healthcare-focus?utm_source=marketbeat.com&utm_medium=referral
OSR Holdings, Inc.: OSR Holdings Eliminates $2.02 Million Warrant Overhang with Premium-Priced Convertible Note
April 10, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-04/68159220-osr-holdings-inc-osr-holdings-eliminates-dollar-2-02-million-warrant-overhang-with-premium-priced-convertible-note-200.htm
See More OSR Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like OSR? Sign up for Earnings360's daily newsletter to receive timely earnings updates on OSR and other key companies, straight to your email.

About OSR

OSR (NASDAQ:OSRH) Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D "platform technologies" versus "assets only" companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea.

View OSR Profile
Earnings Tools